OFIX
Orthofix Medical Inc.
NASDAQ · Healthcare · Medical - Devices · US
$9.07
−11.43%Sep 30, 2026, 13:16 UTC
Carlsmed, Inc. appointed Richard Heppenstall as Chief Financial Officer effective September 28, 2026, with a $500,000 base salary and equity awards valued at $1,400,000 each.
Sep 27, 2026, 11:46 UTC
Juniper Investment Company, LLC, a 10% owner and director of Orthofix Medical Inc., sold 310,000 Orthofix Medical common shares for approximately $2.73 million across September 18 and September 21, 2026.
Source:Aug 5, 2026, 00:00 UTC
Orthofix Medical Inc. reported Q2 2026 net sales of $210.9 million, a 3.8% year-over-year increase, with a GAAP net loss of $15.8 million and diluted EPS of -$0.39.
Source:Jun 11, 2026, 00:00 UTC
Orthofix Medical Inc. elected Alan L. Bazaar, Wayne Burris, Massimo Calafiore, Vickie L. Capps, and Michael M. Finegan as directors effective June 10, 2026.